Corestreet Logo

BridgeBio Pharma Inc (BBIO) Insider Trading

Total insider buys:
  • $127,912,608.53
Total insider sells:
  • $867,555,999.72
Most recent insider trade:
  • April 22, 2025
Most active insider trader:
  • Neil Kumar
Trader NameDateTitleAmountPriceTypeTotal Value
April 22, 2025CEO75,000$34.11Sell$2,558,250.00
April 14, 2025Director10,000$35.00Sell$350,000.00
April 1, 2025Director30,000$34.05Sell$1,021,500.00
March 25, 2025CEO75,000$36.87Sell$2,765,250.00
March 5, 2025Major Shareholder6,000,000$32.96Sell$197,760,000.00
Feb. 25, 2025CFO8,500$33.19Sell$282,115.00
Feb. 25, 2025CEO75,000$33.57Sell$2,517,750.00
Feb. 19, 2025CEO31,543$36.14Sell$1,139,964.02
Feb. 19, 2025CFO4,148$36.16Sell$149,991.68
Jan. 31, 2025Major Shareholder3,065,616$34.90Sell$106,989,998.40
Jan. 28, 2025CFO68,000$36.29Sell$2,467,720.00
Jan. 28, 2025CEO326,932$36.29Sell$11,864,362.28
Nov. 19, 2024CEO27,389$22.41Sell$613,787.49
Nov. 19, 2024CFO4,156$22.41Sell$93,135.96
Sept. 13, 2024Major Shareholder5,800,000$25.75Sell$149,350,000.00
Aug. 19, 2024CFO4,155$24.69Sell$102,586.95
Aug. 19, 2024CEO27,389$24.69Sell$676,234.41
June 3, 2024Director1,000$28.84Sell$28,840.00
March 1, 2024Director2,500$34.00Sell$85,000.00
Jan. 16, 2024Director2,915$37.97Sell$110,682.55
Dec. 26, 2023Director100,000$42.06Sell$4,206,000.00
Dec. 18, 2023Director2,000$40.00Sell$80,000.00
Aug. 17, 2023CEO51,552$28.59Sell$1,473,871.68
Aug. 17, 2023CFO22,683$28.59Sell$648,506.97
July 18, 2023Major Shareholder1,500,000$35.00Sell$52,500,000.00
May 17, 2023CFO24,424$14.01Sell$342,180.24
May 17, 2023CEO51,552$14.01Sell$722,243.52
April 5, 2023CFO55,500$15.45Sell$857,475.00
April 5, 2023CEO120,000$15.46Sell$1,855,200.00
March 3, 2023CEO120,000$10.96Sell$1,315,200.00
March 3, 2023CFO62,692$10.96Sell$687,104.32
Feb. 17, 2023CEO44,798$12.70Sell$568,934.60
Feb. 17, 2023CFO17,717$12.70Sell$225,005.90
Feb. 3, 2023CFO61,040$11.01Sell$672,050.40
Feb. 3, 2023CEO120,000$11.01Sell$1,321,200.00
Jan. 5, 2023CFO61,040$7.67Sell$468,176.80
Jan. 5, 2023CEO120,000$7.67Sell$920,400.00
Nov. 17, 2022CFO19,678$9.40Sell$184,973.20
Nov. 17, 2022CEO34,640$9.40Sell$325,616.00
March 14, 2022Director10,000$8.19Buy$81,900.00
Jan. 4, 2022Director5,000$16.82Buy$84,100.00
Dec. 30, 2021Director10,402$14.34Buy$149,164.68
Dec. 28, 2021Director11,745$12.73Buy$149,513.85
Aug. 4, 2021Insider13,777$53.23Sell$733,349.71
Feb. 17, 2021Director16,000$62.50Buy$1,000,000.00
Feb. 17, 2021Major Shareholder3,450,000$60.47Sell$208,621,500.00
Feb. 17, 2021Insider8,000$62.50Buy$500,000.00
Dec. 28, 2020Insider19,500$69.60Sell$1,357,200.00
Dec. 21, 2020Insider60,401$65.32Sell$3,945,393.32
Dec. 1, 2020Insider10,000$51.52Sell$515,200.00
First«1 of 2»Last

  • Insiders are both buying and selling BridgeBio Pharma Inc stock.

  • The insider traders at BridgeBio Pharma Inc are: Neil Kumar, Brian C Stephenson, Cameron Turtle, Michael Thomas Henderson, Genetic Disorder L.P. Kkr, Randal W Scott, Charles J. Homcy, Frank Mccormick, Global Investors Lp Viking, Ronald J Daniels, Charles J Homcy, Douglas A Dachille, Richard H Scheller, Andrea Ellis, Hannah Valantine, and Brian C. Stephenson

  • The most active insider trader at BridgeBio Pharma Inc is Neil Kumar with 23 trades.

  • Genetic Disorder L.P. Kkr has sold the most BridgeBio Pharma Inc stock with a total value of $833,283,249.10.

  • Global Investors Lp Viking has bought the most BridgeBio Pharma Inc stock with a total value of $160,000,600.00.

  • The most recent insider trade for BridgeBio Pharma Inc was on April 22, 2025.

  • The single biggest insider buy for BridgeBio Pharma Inc was from Global Investors Lp Viking with a total value of $80,000,300.00 on June 27, 2019.

  • The single biggest insider sell for BridgeBio Pharma Inc was from Genetic Disorder L.P. Kkr with a total value of $208,621,500.00 on Feb. 17, 2021.